Researchers at The University of Texas MD Anderson
Cancer Center have developed an ultrasound-guided cancer
immunotherapy platform that generates systemic antitumor immunity
and improves the therapeutic efficacy of immune checkpoint
blockade. The findings from the preclinical study were published
today in Nature Nanotechnology.
If you wish to receive our latest news in your email box, just subscribe to our newsletter. We won’t spam you, we promise!
The New Fusion technology is based on a phenomenon called triplet-triplet annihilation (TTA) which is a process in which two triplet excitons annihilate and produce a higher energy singlet exciton.
If you wish to receive our latest news in your email box, just subscribe to our newsletter. We won’t spam you, we promise!
The New Fusion technology is based on a phenomenon called triplet-triplet annihilation (TTA) which is a process in which two triplet excitons annihilate and produce a higher energy singlet exciton.
